Increased Life Science Sales, Acquisitions Help PerkinElmer Q4 Revenue Grow 10 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer today said fourth-quarter 2006 revenues increased 10 percent as R&D spending rose 29 percent and profit fell 70 percent.
The company also this week declared a quarterly dividend of $.07 per share of common stock, to be payable on May 11.
Total receipts for the three months ended Dec. 31, 2006, increased to $427 million from $388 million year over year, PerkinElmer said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.